Expression analysis of miRNA and target mRNAs in esophageal cancer

Brazilian Journal of Medical and Biological Research

Volumn 47, Issue 9, 2014, Pages 811-817

  Meng, X R ^a   Lu, P ^b   Mei, J Z ^b   Liu, G J ^b   Fan, Q X ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^b ZHENGZHOU PEOPLE S HOSPITAL   (China)

Author keywords

Esophageal adenocarcinoma; Esophageal squamous cell carcinoma; Gene ontology; MiRNA expression network; Pathway

Indexed keywords

MESSENGER RNA; MICRORNA; MICRORNA 202; MICRORNA 203; MICRORNA 205; MICRORNA 21; MICRORNA 223; MICRORNA 375; UNCLASSIFIED DRUG;

ARTICLE; DOWN REGULATION; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS CANCER; GENE EXPRESSION; GENE ONTOLOGY; HUMAN; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PREDICTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SURVIVAL; TRANSCRIPTION REGULATION; UPREGULATION; ADENOCARCINOMA; ESOPHAGUS TUMOR; GENE EXPRESSION PROFILING; GENETICS; MICROARRAY ANALYSIS; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION PROFILING; GENE ONTOLOGY; HUMANS; MICROARRAY ANALYSIS; MICRORNAS; RNA, MESSENGER; SIGNAL TRANSDUCTION; SURVIVAL ANALYSIS;

EID: 84906490456     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/1414-431X20143906     Document Type: Article

References (24)

1. Pennathur A, Gibson MK, Jobe BA, Luketich J.D. Oesophageal carcinoma. Lancet 2013; 381: 400-412, doi: 10.1016/S0140-6736(12)60643-6.
2. Esquela-Kerscher A, Slack F.J. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 2006; 6: 259-269, doi: 10.1038/nrc1840.
3. Ogawa R, Ishiguro H, Kuwabara Y, Kimura M, Mitsui A, Katada T, et al. Expression profiling of micro-RNAs in human esophageal squamous cell carcinoma using RTPCR. Med Mol Morphol 2009; 42: 102-109, doi: 10.1007/s00795-009-0443-1.
4. Stelzl U, Worm U, Lalowski M, Haenig C, Brembeck FH, Goehler H, et al. A human protein-protein interaction network: a resource for annotating the proteome. Cell 2005; 122: 957-968, doi: 10.1016/j.cell.2005.08.029.
5. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003; 4: 249-264, doi: 10.1093/biostatistics/4.2.249.
6. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Stat Soc Series B (Methodological) 1995; 57: 289-300.
7. Smyth GK, Michaud J, Scott H.S. Use of within-array replicate spots for assessing differential expression in microarray experiments. Bioinformatics 2005; 21: 2067-2075, doi: 10.1093/bioinformatics/bti270.
8. Liu BH, Yu H, Tu K, Li C, Li YX, Li Y.Y. DCGL: an R package for identifying differentially coexpressed genes and links from gene expression microarray data. Bioinformatics 2010; 26: 2637-2638, doi: 10.1093/bioinformatics/btq471.
9. Wang X, El Naqa I. Prediction of both conserved and nonconserved microRNA targets in animals. Bioinformatics 2008; 24: 325-332, doi: 10.1093/bioinformatics/btm595.
10. Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 2000; 28: 27-30, doi: 10.1093/nar/28.1.27.
11. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 2000; 25: 25-29, doi: 10.1038/75556.
12. Saad R, Chen Z, Zhu S, Jia P, Zhao Z, Washington MK, et al. Deciphering the unique microRNA signature in human esophageal adenocarcinoma. PLoS One 2013; 8: e64463, doi: 10.1371/journal.pone.0064463.
13. Wu X, Ajani JA, Gu J, Chang DW, Tan W, Hildebrandt MA, et al. MicroRNA expression signatures during malignant progression from Barrett's esophagus to esophageal adenocarcinoma. Cancer Prev Res 2013; 6: 196-205, doi: 10.1158/1940-6207.CAPR-12-0276.
14. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005; 65: 7065-7070, doi: 10.1158/0008-5472.CAN-05-1783.
15. Jiang Z, Guo J, Xiao B, Miao Y, Huang R, Li D, et al. Increased expression of miR-421 in human gastric carcinoma and its clinical association. J Gastroenterol 2010; 45: 17-23, doi: 10.1007/s00535-009-0135-6.
16. Mori Y, Ishiguro H, Kuwabara Y, Kimura M, Mitsui A, Ogawa R, et al. MicroRNA-21 induces cell proliferation and invasion in esophageal squamous cell carcinoma. Mol Med Rep 2009; 2: 235-239.
17. Nouraee N, Van Roosbroeck K, Vasei M, Semnani S, Samaei NM, Naghshvar F, et al. Expression, tissue distribution and function of miR-21 in esophageal squamous cell carcinoma. PLoS One 2013; 8: e73009, doi: 10.1371/journal.pone.0073009.
18. Kurashige J, Watanabe M, Iwatsuki M, Kinoshita K, Saito S, Hiyoshi Y, et al. Overexpression of microRNA-223 regulates the ubiquitin ligase FBXW7 in oesophageal squamous cell carcinoma. Br J Cancer 2012; 106: 182-188, doi: 10.1038/bjc.2011.509.
19. Zhang C, Wang C, Chen X, Yang C, Li K, Wang J, et al. Expression profile of microRNAs in serum: a fingerprint for esophageal squamous cell carcinoma. Clin Chem 2010; 56: 1871-1879, doi: 10.1373/clinchem.2010.147553.
20. Isozaki Y, Hoshino I, Nohata N, Kinoshita T, Akutsu Y, Hanari N, et al. Identification of novel molecular targets regulated by tumor suppressive miR-375 induced by histone acetylation in esophageal squamous cell carcinoma. Int J Oncol 2012; 41: 985-994.
21. Komatsu S, Ichikawa D, Takeshita H, Konishi H, Nagata H, Hirajima S, et al. Prognostic impact of circulating miR-21 and miR-375 in plasma of patients with esophageal squamous cell carcinoma. Expert Opin Biol Ther 2012; 12 (Suppl 1): S53-S59, doi: 10.1517/14712598.2012.681373.
22. Liu AM, Wong KF, Jiang X, Qiao Y, Luk J.M. Regulators of mammalian Hippo pathway in cancer. Biochim Biophys Acta 2012; 1826: 357-364.
23. Song S, Maru DM, Ajani JA, Chan CH, Honjo S, Lin HK, et al. Loss of TGF-beta adaptor beta2SP activates notch signaling and SOX9 expression in esophageal adenocarcinoma. Cancer Res 2013; 73: 2159-2169, doi: 10.1158/0008-5472.CAN-12-1962.
24. You Z, Xu D, Ji J, Guo W, Zhu W, He J. JAK/STAT signal pathway activation promotes progression and survival of human oesophageal squamous cell carcinoma. Clin Transl Oncol 2012; 14: 143-149, doi: 10.1007/s12094-012-0774-6.